Vanberra Signal

GlucoIQ

Curated by Signal

Helps physicians monitor diabetes patients in realtime

Overview

GlucoIQ is clinical decision support software that flags adverse events and highlights patterns in diabetes data. The system processes a combination of data from glucose monitors and insulin pumps, as well as patient lifestyle (including meal and exercise data). GlucoIQ’s dashboard collects data from a wirelessly enabled glucometer in real-time. The company claims its analytics system helps clinicians monitor their patient populations’ health, deliver better care and reduce healthcare costs by improving HbA1c levels.

Key facts

Founded
2015

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of white label virtual health platform for healthcare enterprises

    Health TechnologyLewes, United States
  • Provider of pregnancy due date calculator app for pregnant women

    Health TechnologySimi Valley, United States
  • Digital online communications hub for the biotech community

    Health TechnologyBoston, United States

About GlucoIQ

What does GlucoIQ do?

GlucoIQ is clinical decision support software that flags adverse events and highlights patterns in diabetes data.

Where is GlucoIQ headquartered?

GlucoIQ is headquartered in New York City, United States.

When was GlucoIQ founded?

GlucoIQ was founded in 2015.

Which sector is GlucoIQ in?

GlucoIQ operates in Health Technology.

Who are GlucoIQ's competitors?

Companies similar to GlucoIQ include Medlify, Due Date View, and RApport.